The 2026 ESMO annual meeting featured a rapid oral session and a discussant presentation by Dr. Alison Reid discussing three ...

(UroToday.com) The 2026 European Society of Medical Oncology (ESMO) Annual Congress held the session: Genitourinary tumour, ...

This analysis included 58 patients treated with gemcitabine intravesical system monotherapy in the SunRISe-1 cohort who had ...

(UroToday.com) The 2026 North Central Section of the AUA annual meeting featured a prostate cancer session and a presentation ...

The 2026 North Central Section of the AUA annual meeting featured a urothelial carcinoma session and a presentation by Dr.

The 2026 North Central Section of the AUA annual meeting featured a bladder cancer session and a presentation by Dr. Kaitlin Davis discussing regional disparities in bladder cancer mortality rates.

Spatial Architecture Contributes to Failure of Bulk Biomarker-Guided Neoadjuvant Immunotherapy Selection in Bladder Cancer: The DUTRENEO Study - Beyond the Abstract ...

Age Does Not Independently Predict Biochemical Recurrence in Prostate Cancer Following Radical Prostatectomy: A Comparative Analysis of 4223 pT2N0R0 Patients. October 21, 2026 Mortality in ...

Comprehensive Analysis of microRNA Expression Provides Mechanistic Insights into Transcriptomic Alteration in Primary and Metastatic Testicular Germ Cell Tumors - Beyond the Abstract ...

Membranous Urethral Length as a Predictor for Urinary Incontinence After Holmium Enucleation of the Prostate for Benign Prostatic Hyperplasia - Beyond the Abstract ...

Management of Asymptomatic Bacteriuria and Urinary Tract Infections in Patients with Neurogenic Bladder and Factors Associated with Inappropriate Diagnosis and Treatment - Beyond the Abstract ...

Purine Nucleoside Phosphorylase as a Target for the Treatment of Interstitial Cystitis/Bladder Pain Syndrome with and without Hunner Lesions - Beyond the Abstract ...